125
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Impact of antibiotic prophylaxis and conditioning modalities in per-oral endoscopic myotomy for esophageal motor disorders

, , , , , , , , , , , , ORCID Icon & show all
Pages 1522-1530 | Received 02 May 2022, Accepted 30 Jun 2022, Published online: 18 Jul 2022

References

  • Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42(4):265–271.
  • Ujiki MB, Yetasook AK, Zapf M, et al. Peroral endoscopic myotomy: a short-term comparison with the standard laparoscopic approach. Surgery. 2013;154(4):893–897. discussion 897–900.
  • von Renteln D, Inoue H, Minami H, et al. Peroral endoscopic myotomy for the treatment of achalasia: a prospective single center study. Am J Gastroenterol. 2012;107(3):411–417.
  • Swanstrom LL, Kurian A, Dunst CM, et al. Long-term outcomes of an endoscopic myotomy for achalasia: the POEM procedure. Ann Surg. 2012;256(4):659–667.
  • Kahrilas PJ, Katzka D, Richter JE. Clinical practice update: the use of per-Oral endoscopic myotomy in achalasia: expert review and best practice advice from the AGA institute. Gastroenterology. 2017;153(5):1205–1211.
  • Li QL, Chen WF, Zhou PH, et al. Peroral endoscopic myotomy for the treatment of achalasia: a clinical comparative study of endoscopic full-thickness and circular muscle myotomy. J Am Coll Surg. 2013;217(3):442–451.
  • Nabi Z, Ramchandani M, Reddy DN. Per-oral endoscopic myotomy in achalasia: Which way to go-anterior or posterior? Gastrointest Endosc. 2018;88(3):567.
  • Tan Y, Lv L, Wang X, et al. Efficacy of anterior versus posterior per-oral endoscopic myotomy for treating achalasia: a randomized, prospective study. Gastrointest Endosc. 2018;88(1):46–54.
  • Khashab MA, Chithadi KV, Acosta RD, et al. ASGE Standards of Practice Committee. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2015;81(1):81–89.
  • Khashab MA, Vela MF, Thosani N, et al. ASGE guideline on the management of achalasia. Gastrointest Endosc. 2019;91(2):213–227.e6.
  • Vanbiervliet G. Antibioprophylaxie et endoscopie. Hepato Gastro Oncol Digest. 2016;23(8):769–774.
  • Bayer J, Vackova Z, Svecova H, et al. Gentamicin submucosal lavage during peroral endoscopic myotomy (POEM): a retrospective analysis. Surg Endosc. 2018;32(1):300–306.
  • Kawata N, Tanaka M, Kakushima N, et al. The low incidence of bacteremia after esophageal endoscopic submucosal dissection (ESD) obviates the need for prophylactic antibiotics in esophageal ESD. Surg Endosc. 2016;30(11):5084–5090.
  • Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010;71(3):446–454.
  • Akintoye E, Kumar N, Obaitan I, et al. Peroral endoscopic myotomy: a Meta-analysis. Endoscopy. déc. 2016;48(12):1059–1068.
  • Wang Y, Liu ZQ, Xu MD, et al. Clinical and endoscopic predictors for intraprocedural mucosal injury during per-oral endoscopic myotomy. Gastrointest Endosc. 2019;89(4):769–778.
  • Inoue H, Tianle KM, Ikeda H, et al. Peroral endoscopic myotomy for esophageal achalasia: technique, indication, and outcomes. Thorac Surg Clin. 2011;21(4):519–525.
  • Stavropoulos SN, Modayil RJ, Friedel D, et al. The international per oral endoscopic myotomy survey (IPOEMS): a snapshot of the global POEM experience. Surg Endosc. 2013;27(9):3322–3338.
  • Inoue H, Shiwaku H, Iwakiri K, et al. Clinical practice guidelines for peroral endoscopic myotomy. Dig Endosc. 2018;30(5):563–579.
  • Itaba S, Iboshi Y, Nakamura K, et al. Low-frequency of bacteremia after endoscopic submucosal dissection of the stomach. Dig Endosc. 2011;23(1):69–72.
  • Shehab N, Patel PR, Srinivasan A, et al. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis. 2008;47(6):735–743.
  • Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy. 2020;52(2):127–149.
  • Harris A, Chan AC, Torres-Viera C, Hammett R, et al. Meta-analysis of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy. 1999;31(9):718–724.
  • Bai Y, Gao F, Gao J, et al. Prophylactic antibiotics cannot prevent endoscopic retrograde cholangiopancreatography-induced cholangitis: a Meta-analysis. Pancreas. mars. 2009;38(2):126–130.
  • Brand M, Bizos D, O’Farrell P. Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatography. Cochrane Database Syst Rev. 2010;10:CD007345.
  • Minami T, Sasaki T, Serikawa M, et al. Antibiotic prophylaxis for endoscopic retrograde chlangiopancreatography increases the detection rate of drug-resistant bacteria in bile. J Hepatobiliary Pancreat Sci. 2014;21(9):712–718.
  • Siggens K, Htet H, Aslam SP, et al. Antibiotic prophylaxis for colorectal endoscopic submucosal dissection- is it dogma? Endoscopy 2022;54(S 01):S178.
  • Späth C, Srinivasa S, Walsh M, et al. Role of post-operative serum C-reactive protein levels as a predictor of complications in upper gastrointestinal surgery. ANZ J  Surg. 2019;89(1-2):74–78.
  • Singh PP, Zeng ISL, Srinivasa S, et al. Systematic review and Meta-analysis of use of serum C-reactive protein levels to predict anastomotic leak after colorectal surgery. Br J Surg. 2014;101(4):339–346.
  • Gans SL, Atema JJ, Van Dieren S, et al. Diagnostic value of C-reactive protein to rule out infectious complications after major abdominal surgery: A systematic review and Meta-analysis. Int J Colorectal Dis. 2015;30(7):861–873.
  • Prochazka V, Marek F, Kunovsky L, et al. C-reactive protein as predictor of anastomotic complications after minimally invasive oesophagectomy. J Minim Access Surg. 2019;15(1):46–50.
  • Cheng H, Chen BPH, Soleas IM, et al. Prolonged operative duration increases risk of surgical site infections: a systematic review. Surg Infect. 2017;18(6):722–735.
  • Gomes CF, Revés J, Morão B, et al. Predictive factors for fever after endoscopic submucosal dissection in colorectal lesions. Endoscopy. 2021;53(S 01):S174. Disponible sur: 10.1055/s-0041-1724728

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.